Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Horse Diseases | 6 | 2023 | 54 | 1.970 |
Why?
|
Diabetes, Gestational | 15 | 2024 | 1263 | 1.340 |
Why?
|
Sarcocystosis | 3 | 2023 | 3 | 0.980 |
Why?
|
Sarcocystis | 3 | 2023 | 5 | 0.980 |
Why?
|
Placenta | 14 | 2024 | 1728 | 0.870 |
Why?
|
Glucose Intolerance | 6 | 2024 | 580 | 0.820 |
Why?
|
Pregnancy | 75 | 2024 | 30260 | 0.810 |
Why?
|
Encephalomyelitis | 2 | 2023 | 37 | 0.770 |
Why?
|
Labor, Obstetric | 5 | 2023 | 317 | 0.670 |
Why?
|
Insemination, Artificial | 5 | 2024 | 99 | 0.650 |
Why?
|
Premature Birth | 9 | 2024 | 1829 | 0.650 |
Why?
|
Delivery, Obstetric | 9 | 2024 | 946 | 0.640 |
Why?
|
Postpartum Period | 10 | 2024 | 1205 | 0.630 |
Why?
|
Anti-Mullerian Hormone | 5 | 2023 | 420 | 0.620 |
Why?
|
Cesarean Section | 8 | 2023 | 1431 | 0.580 |
Why?
|
Neospora | 1 | 2017 | 2 | 0.580 |
Why?
|
Coccidiosis | 1 | 2017 | 10 | 0.570 |
Why?
|
Ovulation Induction | 5 | 2024 | 277 | 0.550 |
Why?
|
Pregnancy Outcome | 12 | 2024 | 2966 | 0.530 |
Why?
|
Fertilization in Vitro | 6 | 2024 | 1306 | 0.530 |
Why?
|
Embryo Transfer | 5 | 2024 | 525 | 0.490 |
Why?
|
Horses | 6 | 2023 | 293 | 0.470 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 705 | 0.440 |
Why?
|
Version, Fetal | 2 | 2023 | 20 | 0.420 |
Why?
|
Breech Presentation | 2 | 2023 | 38 | 0.420 |
Why?
|
Glucose Tolerance Test | 10 | 2024 | 1180 | 0.400 |
Why?
|
Gonadotropins | 2 | 2024 | 240 | 0.380 |
Why?
|
Polycystic Ovary Syndrome | 3 | 2021 | 389 | 0.380 |
Why?
|
Suburethral Slings | 2 | 2023 | 69 | 0.370 |
Why?
|
Pregnancy Rate | 7 | 2024 | 655 | 0.370 |
Why?
|
Labor, Induced | 3 | 2021 | 153 | 0.370 |
Why?
|
Live Birth | 5 | 2022 | 516 | 0.360 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2022 | 2187 | 0.340 |
Why?
|
Endometrium | 2 | 2024 | 406 | 0.320 |
Why?
|
Placenta Diseases | 2 | 2023 | 199 | 0.320 |
Why?
|
Prenatal Care | 4 | 2020 | 1160 | 0.310 |
Why?
|
Female | 94 | 2024 | 396112 | 0.300 |
Why?
|
Vaginal Diseases | 2 | 2019 | 103 | 0.300 |
Why?
|
Infertility, Female | 4 | 2024 | 763 | 0.290 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2024 | 532 | 0.290 |
Why?
|
Blood Glucose | 10 | 2024 | 6424 | 0.280 |
Why?
|
Postpartum Hemorrhage | 2 | 2021 | 276 | 0.280 |
Why?
|
Clomiphene | 2 | 2024 | 71 | 0.270 |
Why?
|
Labor Stage, Second | 2 | 2024 | 45 | 0.270 |
Why?
|
Fertility Agents, Female | 2 | 2024 | 101 | 0.270 |
Why?
|
Fetal Blood | 3 | 2023 | 1369 | 0.260 |
Why?
|
Apgar Score | 2 | 2024 | 124 | 0.260 |
Why?
|
Infertility | 2 | 2023 | 654 | 0.260 |
Why?
|
Glucose | 6 | 2023 | 4335 | 0.250 |
Why?
|
Infant, Newborn | 21 | 2024 | 26346 | 0.250 |
Why?
|
Pain, Postoperative | 4 | 2021 | 1772 | 0.240 |
Why?
|
Obstetrics | 3 | 2024 | 680 | 0.240 |
Why?
|
Insulin Resistance | 3 | 2024 | 3985 | 0.240 |
Why?
|
Term Birth | 3 | 2021 | 140 | 0.230 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2024 | 83 | 0.230 |
Why?
|
Retrospective Studies | 35 | 2024 | 81514 | 0.230 |
Why?
|
Insurance, Health | 4 | 2021 | 2521 | 0.220 |
Why?
|
Urinary Incontinence, Stress | 2 | 2023 | 180 | 0.220 |
Why?
|
Gynecology | 2 | 2021 | 535 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 125 | 0.220 |
Why?
|
Oocyte Retrieval | 2 | 2021 | 163 | 0.210 |
Why?
|
Natural Language Processing | 2 | 2022 | 1203 | 0.210 |
Why?
|
Information Seeking Behavior | 1 | 2024 | 116 | 0.210 |
Why?
|
Betamethasone | 1 | 2022 | 48 | 0.200 |
Why?
|
Humans | 94 | 2024 | 765968 | 0.200 |
Why?
|
Birth Weight | 4 | 2024 | 2121 | 0.200 |
Why?
|
Burnout, Professional | 2 | 2022 | 711 | 0.200 |
Why?
|
Medicaid | 3 | 2021 | 2833 | 0.200 |
Why?
|
Fetal Macrosomia | 2 | 2024 | 139 | 0.200 |
Why?
|
Reproductive Techniques, Assisted | 2 | 2024 | 501 | 0.200 |
Why?
|
Pregnancy Complications | 5 | 2024 | 2975 | 0.200 |
Why?
|
Hospitals | 3 | 2021 | 3888 | 0.200 |
Why?
|
Adult | 47 | 2024 | 223044 | 0.200 |
Why?
|
Toxoplasma | 1 | 2023 | 158 | 0.190 |
Why?
|
Infant, Newborn, Diseases | 3 | 2024 | 587 | 0.190 |
Why?
|
Erbovirus | 1 | 2021 | 1 | 0.190 |
Why?
|
Parity | 5 | 2023 | 931 | 0.190 |
Why?
|
Psychological Tests | 1 | 2023 | 644 | 0.190 |
Why?
|
Bodily Secretions | 1 | 2021 | 28 | 0.180 |
Why?
|
Gestational Age | 7 | 2024 | 3609 | 0.180 |
Why?
|
Pelvic Organ Prolapse | 1 | 2023 | 116 | 0.180 |
Why?
|
Abortion, Spontaneous | 3 | 2021 | 536 | 0.180 |
Why?
|
Equidae | 1 | 2020 | 10 | 0.180 |
Why?
|
Pregnancy in Diabetics | 1 | 2022 | 198 | 0.180 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2020 | 30 | 0.180 |
Why?
|
Carcinoma, Endometrioid | 1 | 2023 | 272 | 0.180 |
Why?
|
Anovulation | 1 | 2020 | 55 | 0.180 |
Why?
|
Fetal Resorption | 1 | 2020 | 15 | 0.180 |
Why?
|
Antibodies, Protozoan | 2 | 2023 | 250 | 0.180 |
Why?
|
Obstetric Labor Complications | 2 | 2024 | 240 | 0.170 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.170 |
Why?
|
Anal Canal | 1 | 2023 | 376 | 0.170 |
Why?
|
Serum Albumin | 1 | 2023 | 675 | 0.170 |
Why?
|
Hypoglycemia | 2 | 2024 | 896 | 0.170 |
Why?
|
Asthma | 3 | 2023 | 6270 | 0.170 |
Why?
|
Picornaviridae Infections | 1 | 2021 | 97 | 0.170 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2021 | 1354 | 0.170 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2023 | 361 | 0.160 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1024 | 0.160 |
Why?
|
Counseling | 2 | 2024 | 1551 | 0.160 |
Why?
|
Analgesia, Epidural | 1 | 2022 | 337 | 0.160 |
Why?
|
Pelvis | 2 | 2023 | 738 | 0.160 |
Why?
|
Follicular Phase | 1 | 2019 | 143 | 0.160 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3211 | 0.160 |
Why?
|
Carbohydrate Metabolism | 1 | 2020 | 261 | 0.160 |
Why?
|
Dystocia | 1 | 2018 | 33 | 0.150 |
Why?
|
Vulvar Diseases | 1 | 2019 | 66 | 0.150 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 453 | 0.150 |
Why?
|
Fecal Incontinence | 1 | 2021 | 245 | 0.150 |
Why?
|
Obstetric Labor, Premature | 1 | 2020 | 268 | 0.150 |
Why?
|
Attitude of Health Personnel | 2 | 2024 | 3925 | 0.150 |
Why?
|
Chorioamnionitis | 1 | 2019 | 155 | 0.140 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2021 | 395 | 0.140 |
Why?
|
Abruptio Placentae | 1 | 2019 | 115 | 0.140 |
Why?
|
Insurance Coverage | 2 | 2019 | 1944 | 0.140 |
Why?
|
Electronic Health Records | 4 | 2022 | 4873 | 0.140 |
Why?
|
Preconception Care | 1 | 2018 | 142 | 0.140 |
Why?
|
Dental Care | 1 | 2020 | 286 | 0.140 |
Why?
|
Acetaminophen | 1 | 2021 | 547 | 0.140 |
Why?
|
Ureter | 1 | 2020 | 364 | 0.140 |
Why?
|
Nose | 1 | 2021 | 519 | 0.140 |
Why?
|
Risk Factors | 17 | 2024 | 74840 | 0.140 |
Why?
|
Preimplantation Diagnosis | 1 | 2019 | 143 | 0.140 |
Why?
|
Medically Uninsured | 2 | 2021 | 838 | 0.140 |
Why?
|
Aorta, Abdominal | 1 | 2020 | 596 | 0.140 |
Why?
|
Bronchiolitis | 1 | 2023 | 493 | 0.140 |
Why?
|
Urinary Incontinence | 1 | 2021 | 491 | 0.130 |
Why?
|
Staff Development | 1 | 2018 | 230 | 0.130 |
Why?
|
Dietary Carbohydrates | 1 | 2021 | 894 | 0.130 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2024 | 855 | 0.130 |
Why?
|
Cervix Uteri | 1 | 2020 | 579 | 0.130 |
Why?
|
Urology | 1 | 2021 | 384 | 0.130 |
Why?
|
Inservice Training | 1 | 2018 | 375 | 0.130 |
Why?
|
Cross-Sectional Studies | 10 | 2024 | 26318 | 0.130 |
Why?
|
Puerperal Disorders | 1 | 2018 | 306 | 0.120 |
Why?
|
Emergency Treatment | 1 | 2019 | 494 | 0.120 |
Why?
|
Fever | 2 | 2021 | 1603 | 0.120 |
Why?
|
Celiac Disease | 1 | 2023 | 820 | 0.120 |
Why?
|
Premenopause | 1 | 2019 | 1037 | 0.120 |
Why?
|
Bupivacaine | 1 | 2018 | 432 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 778 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2018 | 723 | 0.120 |
Why?
|
Physicians, Women | 1 | 2021 | 512 | 0.120 |
Why?
|
International Classification of Diseases | 1 | 2020 | 935 | 0.120 |
Why?
|
Liposomes | 1 | 2018 | 788 | 0.110 |
Why?
|
Cryopreservation | 1 | 2019 | 728 | 0.110 |
Why?
|
Ovarian Neoplasms | 2 | 2023 | 4900 | 0.110 |
Why?
|
Leiomyoma | 1 | 2019 | 643 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1511 | 0.110 |
Why?
|
Endometrial Neoplasms | 1 | 2023 | 1378 | 0.110 |
Why?
|
Embryo, Mammalian | 1 | 2019 | 1673 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5891 | 0.110 |
Why?
|
Health Services Research | 1 | 2020 | 1808 | 0.100 |
Why?
|
Qualitative Research | 1 | 2024 | 3139 | 0.100 |
Why?
|
Hysterectomy | 1 | 2018 | 864 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 830 | 0.100 |
Why?
|
Maternal Health Services | 1 | 2018 | 472 | 0.100 |
Why?
|
Analgesics, Opioid | 2 | 2019 | 3835 | 0.100 |
Why?
|
Insemination | 2 | 2022 | 18 | 0.100 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2019 | 1188 | 0.100 |
Why?
|
Self Report | 1 | 2023 | 3770 | 0.100 |
Why?
|
Cohort Studies | 10 | 2024 | 41649 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4528 | 0.100 |
Why?
|
Risk Assessment | 6 | 2024 | 24282 | 0.100 |
Why?
|
Anesthetics, Local | 1 | 2018 | 1015 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2023 | 2531 | 0.090 |
Why?
|
Morbidity | 3 | 2021 | 1749 | 0.090 |
Why?
|
Logistic Models | 5 | 2024 | 13266 | 0.090 |
Why?
|
Neoplastic Stem Cells | 1 | 2018 | 1352 | 0.090 |
Why?
|
Stillbirth | 2 | 2024 | 381 | 0.090 |
Why?
|
Postmenopause | 1 | 2019 | 2515 | 0.080 |
Why?
|
Microglia | 1 | 2018 | 1372 | 0.080 |
Why?
|
Physicians | 3 | 2024 | 4588 | 0.080 |
Why?
|
DNA Repair | 1 | 2018 | 2048 | 0.080 |
Why?
|
Prospective Studies | 9 | 2023 | 54802 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3278 | 0.080 |
Why?
|
Amniotic Fluid | 2 | 2023 | 380 | 0.080 |
Why?
|
Infant, Small for Gestational Age | 2 | 2024 | 469 | 0.080 |
Why?
|
United States | 10 | 2024 | 72903 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2047 | 0.070 |
Why?
|
Parturition | 2 | 2023 | 454 | 0.070 |
Why?
|
Macrophages | 2 | 2023 | 5772 | 0.070 |
Why?
|
Massachusetts | 4 | 2023 | 8875 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10603 | 0.070 |
Why?
|
Primary Health Care | 1 | 2024 | 4736 | 0.070 |
Why?
|
Patient Readmission | 1 | 2021 | 3286 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3615 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2659 | 0.070 |
Why?
|
Young Adult | 10 | 2024 | 59889 | 0.070 |
Why?
|
Steroids | 2 | 2022 | 933 | 0.070 |
Why?
|
Prevalence | 3 | 2021 | 15842 | 0.070 |
Why?
|
Body Mass Index | 2 | 2022 | 13039 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7478 | 0.060 |
Why?
|
Thrombosis | 1 | 2019 | 2949 | 0.060 |
Why?
|
HIV Infections | 2 | 2023 | 17533 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3645 | 0.060 |
Why?
|
Pregnant Women | 2 | 2021 | 575 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2023 | 15747 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2429 | 0.060 |
Why?
|
Animals | 7 | 2023 | 168764 | 0.060 |
Why?
|
Cardiotocography | 1 | 2024 | 33 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7066 | 0.060 |
Why?
|
Hyperbilirubinemia, Neonatal | 1 | 2024 | 31 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4300 | 0.050 |
Why?
|
Trophoblasts | 1 | 2024 | 223 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4863 | 0.050 |
Why?
|
Quality of Life | 2 | 2021 | 13462 | 0.050 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2024 | 239 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5508 | 0.050 |
Why?
|
Postnatal Care | 1 | 2024 | 275 | 0.050 |
Why?
|
Male | 12 | 2024 | 363698 | 0.050 |
Why?
|
New England | 1 | 2024 | 1059 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2019 | 3100 | 0.050 |
Why?
|
Blastocyst | 1 | 2024 | 432 | 0.050 |
Why?
|
Chorionic Gonadotropin | 1 | 2023 | 457 | 0.040 |
Why?
|
Appointments and Schedules | 1 | 2024 | 444 | 0.040 |
Why?
|
Infant | 4 | 2023 | 36386 | 0.040 |
Why?
|
Perioperative Period | 1 | 2021 | 251 | 0.040 |
Why?
|
Middle Aged | 10 | 2024 | 223009 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 404 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2023 | 22223 | 0.040 |
Why?
|
Cervical Length Measurement | 1 | 2020 | 47 | 0.040 |
Why?
|
Pain Measurement | 2 | 2021 | 3561 | 0.040 |
Why?
|
Triazines | 1 | 2021 | 307 | 0.040 |
Why?
|
Fentanyl | 1 | 2022 | 457 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2022 | 20124 | 0.040 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2024 | 595 | 0.040 |
Why?
|
Meconium | 1 | 2019 | 47 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10808 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 1 | 2021 | 731 | 0.040 |
Why?
|
Pregnancy, Multiple | 1 | 2019 | 216 | 0.040 |
Why?
|
Individuality | 1 | 2020 | 303 | 0.040 |
Why?
|
Uterine Inertia | 1 | 2018 | 29 | 0.040 |
Why?
|
Uganda | 1 | 2023 | 1353 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 384 | 0.040 |
Why?
|
Fetal Development | 1 | 2024 | 777 | 0.040 |
Why?
|
Vaccination | 2 | 2022 | 3426 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 587 | 0.040 |
Why?
|
Surgical Mesh | 1 | 2021 | 315 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2022 | 549 | 0.040 |
Why?
|
Fertilization | 1 | 2018 | 197 | 0.040 |
Why?
|
Pregnancy, High-Risk | 1 | 2018 | 121 | 0.040 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2018 | 212 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1125 | 0.040 |
Why?
|
Insulin | 2 | 2023 | 6599 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2020 | 559 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1259 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2018 | 508 | 0.030 |
Why?
|
Placebos | 1 | 2021 | 1659 | 0.030 |
Why?
|
Influenza A virus | 1 | 2020 | 453 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2020 | 737 | 0.030 |
Why?
|
Cough | 1 | 2021 | 597 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1638 | 0.030 |
Why?
|
Botswana | 1 | 2020 | 1057 | 0.030 |
Why?
|
Ovary | 1 | 2021 | 956 | 0.030 |
Why?
|
Critical Pathways | 1 | 2020 | 474 | 0.030 |
Why?
|
Nitriles | 1 | 2021 | 982 | 0.030 |
Why?
|
ROC Curve | 1 | 2024 | 3620 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1528 | 0.030 |
Why?
|
Nasal Mucosa | 1 | 2019 | 416 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
Maternal Age | 1 | 2018 | 804 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1884 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10563 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2020 | 834 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2652 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1589 | 0.030 |
Why?
|
Eating | 1 | 2021 | 1540 | 0.030 |
Why?
|
Adolescent | 5 | 2021 | 88835 | 0.030 |
Why?
|
Fetus | 1 | 2021 | 1870 | 0.030 |
Why?
|
Delphi Technique | 1 | 2018 | 893 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21480 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2021 | 1268 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6274 | 0.030 |
Why?
|
Mothers | 1 | 2024 | 2210 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8703 | 0.030 |
Why?
|
Antibodies | 1 | 2021 | 2417 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2022 | 1880 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2354 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15880 | 0.030 |
Why?
|
HIV | 1 | 2020 | 1585 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3315 | 0.020 |
Why?
|
RNA, Viral | 1 | 2020 | 2864 | 0.020 |
Why?
|
Feces | 1 | 2019 | 1504 | 0.020 |
Why?
|
Program Development | 1 | 2018 | 1295 | 0.020 |
Why?
|
Focus Groups | 1 | 2018 | 1459 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2446 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2023 | 59489 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3386 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2780 | 0.020 |
Why?
|
Educational Measurement | 1 | 2018 | 1260 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5876 | 0.020 |
Why?
|
Educational Status | 1 | 2018 | 2513 | 0.020 |
Why?
|
Menopause | 1 | 2019 | 1659 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2216 | 0.020 |
Why?
|
Health Surveys | 1 | 2021 | 4056 | 0.020 |
Why?
|
Preoperative Care | 1 | 2020 | 2267 | 0.020 |
Why?
|
Child | 3 | 2023 | 80564 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8733 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6499 | 0.020 |
Why?
|
Child, Preschool | 2 | 2023 | 42500 | 0.020 |
Why?
|
Women's Health | 1 | 2019 | 2084 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4058 | 0.020 |
Why?
|
Nurses | 1 | 2019 | 2505 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9347 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7584 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6322 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1806 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29922 | 0.020 |
Why?
|
Medical Oncology | 1 | 2020 | 2339 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11206 | 0.020 |
Why?
|
Terminal Care | 1 | 2020 | 1774 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7232 | 0.020 |
Why?
|
Aged | 4 | 2023 | 171117 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9525 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4348 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12437 | 0.020 |
Why?
|
Poverty | 1 | 2018 | 2714 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12509 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9649 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9338 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12976 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8297 | 0.010 |
Why?
|
Curriculum | 1 | 2018 | 3782 | 0.010 |
Why?
|
Decision Making | 1 | 2018 | 3965 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3230 | 0.010 |
Why?
|
Depression | 1 | 2023 | 8237 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14751 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3853 | 0.010 |
Why?
|
Diet | 1 | 2021 | 8086 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 65188 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13076 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14071 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40065 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20659 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36532 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81819 | 0.010 |
Why?
|